Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia

NCT06187285 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Empagliflozin 25 MG
DRUG: Sitagliptin 100mg

Sponsor

Medanta, The Medicity, India

Collaborators

[object Object]